Gary W. Miller - Publications

Affiliations: 
2002-2018 Emory University, Atlanta, GA 
 2018- Columbia University, New York, NY 
Area:
dopamine, Parkinsons disease
Website:
https://www.mailman.columbia.edu/people/our-faculty/gm2815

132 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kalia V, Belsky DW, Baccarelli AA, Miller GW. An exposomic framework to uncover environmental drivers of aging. Exposome. 2: osac002. PMID 35295547 DOI: 10.1093/exposome/osac002  0.68
2022 McIntyre LM, Huertas F, Morse AM, Kaletsky R, Murphy CT, Kalia V, Miller GW, Moskalenko O, Conesa A, Mor DE. GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson's disease. Scientific Reports. 12: 3268. PMID 35228596 DOI: 10.1038/s41598-022-07238-9  0.724
2022 Reuben A, Manczak EM, Cabrera LY, Alegria M, Bucher ML, Freeman EC, Miller GW, Solomon GM, Perry MJ. The Interplay of Environmental Exposures and Mental Health: Setting an Agenda. Environmental Health Perspectives. 130: 25001. PMID 35171017 DOI: 10.1289/EHP9889  0.756
2022 Caudle WM, Richardson JR, Delea KC, Guillot TS, Wang M, Pennell KD, Miller GW. Corrigendum to: Polychlorinated Biphenyl-Induced Reduction of Dopamine Transporter Expression as a Precursor to Parkinson's Disease-Associated Dopamine Toxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 35079840 DOI: 10.1093/toxsci/kfab155  0.856
2021 Vecchio LM, Sullivan P, Dunn AR, Bermejo MK, Fu R, Masoud ST, Gregersen E, Urs NM, Nazari R, Jensen PH, Ramsey A, Goldstein DS, Miller GW, Salahpour A. Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Journal of Neurochemistry. PMID 33991113 DOI: 10.1111/jnc.15432  0.809
2021 Cui K, Yang F, Tufan T, Raza MU, Zhan Y, Fan Y, Zeng F, Brown RW, Price JB, Jones TC, Miller GW, Zhu MY. Restoration of Noradrenergic Function in Parkinson's Disease Model Mice. Asn Neuro. 13: 17590914211009730. PMID 33940943 DOI: 10.1177/17590914211009730  0.386
2021 Bradner JM, Kalia V, Lau FK, Sharma M, Bucher ML, Johnson M, Chen M, Walker DI, Jones DP, Miller GW. Genetic or toxicant-induced disruption of vesicular monoamine storage and global metabolic profiling in Caenorhabditis elegans. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 33538833 DOI: 10.1093/toxsci/kfab011  0.821
2020 Black CA, Bucher ML, Bradner JM, Jonas L, Igarza K, Miller GW. Assessing Vesicular Monoamine Transport and Toxicity Using Fluorescent False Neurotransmitters. Chemical Research in Toxicology. PMID 33378168 DOI: 10.1021/acs.chemrestox.0c00380  0.84
2020 Mor DE, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V, Miller GW, Murphy CT. Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria. Proceedings of the National Academy of Sciences of the United States of America. PMID 33024014 DOI: 10.1073/pnas.2009838117  0.725
2020 Burkett JP, Miller GW. Using the exposome to understand environmental contributors to psychiatric disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32913344 DOI: 10.1038/s41386-020-00851-0  0.678
2020 Kalia V, Walker DI, Krasnodemski KM, Jones DP, Miller GW, Kioumourtzoglou MA. Unsupervised dimensionality reduction for exposome research. Current Opinion in Environmental Science & Health. 15: 32-38. PMID 32905218 DOI: 10.1016/J.Coesh.2020.05.001  0.68
2020 Dupre TV, Schnellmann RG, Miller GW. Using the exposome to address gene-environment interactions in kidney disease. Nature Reviews. Nephrology. PMID 32393897 DOI: 10.1038/s41581-020-0302-9  0.427
2020 Vardarajan B, Kalia V, Manly J, Brickman A, Reyes-Dumeyer D, Lantigua R, Ionita-Laza I, Jones DP, Miller GW, Mayeux R. Differences in plasma metabolites related to Alzheimer's disease, ε4 status, and ethnicity. Alzheimer's & Dementia (New York, N. Y.). 6: e12025. PMID 32377558 DOI: 10.1002/Trc2.12025  0.671
2020 Branco RC, Burkett JP, Black CA, Winokur E, Elsworth W, Dhamsania RK, Lohr KM, Schroeder JP, Weinshenker D, Jovanovic T, Miller GW. Vesicular monoamine transporter 2 mediates fear behavior in mice. Genes, Brain, and Behavior. e12634. PMID 31898856 DOI: 10.1111/Gbb.12634  0.823
2019 Stout K, Dunn A, Hoffman C, Miller GW. The synaptic vesicle glycoprotein 2: structure, function, and disease relevance. Acs Chemical Neuroscience. PMID 31394034 DOI: 10.1021/Acschemneuro.9B00351  0.788
2019 Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D. Selective D and D receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30879021 DOI: 10.1038/S41386-019-0371-2  0.778
2018 Stout K, Bernaskova M, Miller GW, Hufner A, Schuehly W. Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine Transporter. Molecules (Basel, Switzerland). 23. PMID 30287800 DOI: 10.3390/Molecules23102536  0.717
2018 Steves AN, Turry A, Gill B, Clarkson-Townsend D, Bradner JM, Bachli I, Caudle WM, Miller GW, Chan AWS, Easley CA. Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model. Systems Biology in Reproductive Medicine. 1-15. PMID 29911897 DOI: 10.1080/19396368.2018.1481465  0.657
2018 Steves AN, Bradner JM, Fowler KL, Clarkson-Townsend D, Gill BJ, Turry AC, Caudle WM, Miller GW, Chan AWS, Easley CA. Ubiquitous Flame-Retardant Toxicants Impair Spermatogenesis in a Human Stem Cell Model. Iscience. 3: 161-176. PMID 29901031 DOI: 10.1016/j.isci.2018.04.014  0.655
2018 Bhattacharya S, Ma Y, Dunn AR, Bradner JM, Scimemi A, Miller GW, Traynelis SF, Wichmann T. NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate. Journal of Neuroscience Research. PMID 29577359 DOI: 10.1002/Jnr.24230  0.612
2017 Dunn AR, Hoffman CA, Stout KA, Ozawa M, Dhamsania RK, Miller GW. Immunochemical Analysis Of The Expression Of Sv2c In Mouse, Macaque And Human Brain. Brain Research. PMID 29274878 DOI: 10.1016/J.Brainres.2017.12.029  0.815
2017 Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WM, Miller GW. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28246328 DOI: 10.1073/Pnas.1616892114  0.828
2016 Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, Winokur EJ, Burkett J, Shmitz Y, Caudle WM, Miller GW. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. Journal of Chemical Neuroanatomy. PMID 27836486 DOI: 10.1016/J.Jchemneu.2016.11.003  0.785
2016 Lohr KM, Masoud ST, Salahpour A, Miller GW. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. The European Journal of Neuroscience. PMID 27520881 DOI: 10.1111/Ejn.13357  0.863
2016 Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW. Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice. Acs Chemical Neuroscience. PMID 27501345 DOI: 10.1021/Acschemneuro.6B00131  0.808
2016 Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR, Wang M, Bernstein A, Miller GW. Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27287315 DOI: 10.1093/Toxsci/Kfw106  0.852
2016 Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, ... ... Miller GW, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/Journal.Pone.0150602  0.76
2016 Trossbach SV, Bader V, Hecher L, Pum ME, Masoud ST, Prikulis I, Schäble S, de Souza Silva MA, Su P, Boulat B, Chwiesko C, Poschmann G, Stühler K, Lohr KM, Stout KA, ... ... Miller GW, et al. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Molecular Psychiatry. PMID 26754951 DOI: 10.1038/Mp.2015.194  0.84
2015 Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. PMID 26428905 DOI: 10.1016/J.Expneurol.2015.09.016  0.802
2015 Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H. Selective Expression of Parkinson's disease-related Leucine-rich Repeat Kinase 2 G2019S Missense Mutation in Midbrain Dopaminergic Neurons Impairs Dopamine Release and Dopaminergic Gene Expression. Human Molecular Genetics. PMID 26123485 DOI: 10.1093/Hmg/Ddv249  0.778
2015 Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Acs Chemical Neuroscience. 6: 790-9. PMID 25746685 DOI: 10.1021/Acschemneuro.5B00010  0.854
2015 Richardson JR, Taylor MM, Shalat SL, Guillot TS, Caudle WM, Hossain MM, Mathews TA, Jones SR, Cory-Slechta DA, Miller GW. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1960-72. PMID 25630971 DOI: 10.1096/Fj.14-260901  0.778
2015 Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, et al. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiology of Disease. 74: 66-75. PMID 25447236 DOI: 10.1016/J.Nbd.2014.10.016  0.862
2014 Lohr KM, Miller GW. VMAT2 and Parkinson's disease: harnessing the dopamine vesicle. Expert Review of Neurotherapeutics. 14: 1115-7. PMID 25220836 DOI: 10.1586/14737175.2014.960399  0.805
2014 Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, ... Miller GW, et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: 9977-82. PMID 24979780 DOI: 10.1073/Pnas.1402134111  0.842
2014 Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease. Journal of Neurochemistry. PMID 24848581 DOI: 10.1111/Jnc.12766  0.424
2014 Gyoneva S, Shapiro L, Lazo C, Garnier-Amblard E, Smith Y, Miller GW, Traynelis SF. Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease. Neurobiology of Disease. 67: 191-202. PMID 24632419 DOI: 10.1016/J.Nbd.2014.03.004  0.356
2014 Bernstein AI, Stout KA, Miller GW. The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochemistry International. 73: 89-97. PMID 24398404 DOI: 10.1016/J.Neuint.2013.12.003  0.813
2014 Qi Z, Miller GW, Voit EO. Rotenone and paraquat perturb dopamine metabolism: A computational analysis of pesticide toxicity. Toxicology. 315: 92-101. PMID 24269752 DOI: 10.1016/J.Tox.2013.11.003  0.493
2014 Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76: 97-105. PMID 24025942 DOI: 10.1016/J.Neuropharm.2013.08.033  0.855
2013 Inamdar AA, Hossain MM, Bernstein AI, Miller GW, Richardson JR, Bennett JW. Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 110: 19561-6. PMID 24218591 DOI: 10.1073/Pnas.1318830110  0.858
2013 Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, ... ... Miller GW, et al. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environmental Health Perspectives. 121: 1245-52. PMID 23933572 DOI: 10.1289/Ehp.1306967  0.376
2013 Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. Journal of Neurochemistry. 126: 591-603. PMID 23786406 DOI: 10.1111/Jnc.12345  0.847
2013 Alter SP, Lenzi GM, Bernstein AI, Miller GW. Vesicular integrity in Parkinson's disease. Current Neurology and Neuroscience Reports. 13: 362. PMID 23690026 DOI: 10.1007/S11910-013-0362-3  0.854
2013 Pranski EL, Dalal NV, Sanford CV, Herskowitz JH, Gearing M, Lazo C, Miller GW, Lah JJ, Levey AI, Betarbet RS. RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells. Neurobiology of Disease. 54: 264-79. PMID 23318928 DOI: 10.1016/J.Nbd.2012.12.018  0.558
2013 Bradner JM, Suragh TA, Wilson WW, Lazo CR, Stout KA, Kim HM, Wang MZ, Walker DI, Pennell KD, Richardson JR, Miller GW, Caudle WM. Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity. Experimental Neurology. 241: 138-47. PMID 23287494 DOI: 10.1016/J.Expneurol.2012.12.013  0.866
2013 Alter SP, Taylor TN, Sullivan P, Goldstein DS, Miller GW. Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 125. DOI: 10.1016/B978-0-12-800044-1.00108-2  0.815
2012 Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson's disease neuropathology. Neurotoxicology. 33: 1298-304. PMID 22906799 DOI: 10.1016/J.Neuro.2012.08.002  0.532
2012 Caudle WM, Guillot TS, Lazo C, Miller GW. Parkinson's disease and the environment: beyond pesticides. Neurotoxicology. 33: 585. PMID 22774228 DOI: 10.1016/j.neuro.2012.04.011  0.792
2012 Dean ED, Mexas LM, Cápiro NL, McKeon JE, DeLong MR, Pennell KD, Doorn JA, Tangpricha V, Miller GW, Evatt ML. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. Plos One. 7: e39227. PMID 22768297 DOI: 10.1371/Journal.Pone.0039227  0.462
2012 Bernstein AI, Stout KA, Miller GW. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport. Journal of Neuroscience Methods. 209: 357-66. PMID 22698664 DOI: 10.1016/J.Jneumeth.2012.06.002  0.814
2012 Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson's disease. Neurotoxicology. 33: 178-88. PMID 22309908 DOI: 10.1016/J.Neuro.2012.01.010  0.796
2012 Qi Z, Miller GW, Voit EO. Mathematical models of dopamine metabolism in parkinson’s disease Systems Biology of Parkinson's Disease. 151-171. DOI: 10.1007/978-1-4614-3411-5_8  0.316
2011 Taylor TN, Caudle WM, Miller GW. VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinson's Disease. 2011: 124165. PMID 21403896 DOI: 10.4061/2011/124165  0.831
2011 She H, Yang Q, Shepherd K, Smith Y, Miller G, Testa C, Mao Z. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. The Journal of Clinical Investigation. 121: 930-40. PMID 21393861 DOI: 10.1172/Jci43871  0.77
2010 Qi Z, Miller GW, Voit EO. The internal state of medium spiny neurons varies in response to different input signals. Bmc Systems Biology. 4: 26. PMID 20236543 DOI: 10.1186/1752-0509-4-26  0.376
2010 Bernstein AI, Miller GW. Oxidative signaling in experimental autoimmune encephalomyelitis. Toxicological Sciences : An Official Journal of the Society of Toxicology. 114: 159-61. PMID 20234054 DOI: 10.1093/Toxsci/Kfq012  0.74
2010 Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson's disease. Behavioural Brain Research. 211: 1-10. PMID 20211655 DOI: 10.1016/J.Bbr.2010.03.004  0.608
2010 Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proceedings of the National Academy of Sciences of the United States of America. 107: 2687-92. PMID 20133810 DOI: 10.1073/Pnas.0913572107  0.766
2009 Qi Z, Miller GW, Voit EO. Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals. Synapse (New York, N.Y.). 63: 1133-42. PMID 19670315 DOI: 10.1002/Syn.20686  0.554
2009 Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8103-13. PMID 19553450 DOI: 10.1523/Jneurosci.1495-09.2009  0.822
2009 Guillot TS, Miller GW. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Molecular Neurobiology. 39: 149-70. PMID 19259829 DOI: 10.1007/s12035-009-8059-y  0.823
2008 Guillot TS, Asress SA, Richardson JR, Glass JD, Miller GW. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. Journal of Motor Behavior. 40: 568-77. PMID 18980909 DOI: 10.3200/JMBR.40.6.568-577  0.8
2008 Qi Z, Miller GW, Voit EO. A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia. Pharmacopsychiatry. 41: S89-98. PMID 18756426 DOI: 10.1055/S-2008-1080936  0.487
2008 Guillot TS, Shepherd KR, Richardson JR, Wang MZ, Li Y, Emson PC, Miller GW. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. Journal of Neurochemistry. 106: 2205-17. PMID 18643795 DOI: 10.1111/J.1471-4159.2008.05568.X  0.843
2008 Richardson JR, Caudle WM, Wang MZ, Dean ED, Pennell KD, Miller GW. Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Neurotoxicology. 29: 855-63. PMID 18577399 DOI: 10.1016/J.Neuro.2008.05.007  0.815
2008 Qi Z, Miller GW, Voit EO. Computational systems analysis of dopamine metabolism. Plos One. 3: e2444. PMID 18568086 DOI: 10.1371/Journal.Pone.0002444  0.532
2008 Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochemical Pharmacology. 76: 569-81. PMID 18555207 DOI: 10.1016/J.Bcp.2008.05.010  0.489
2008 Hatcher JM, Delea KC, Richardson JR, Pennell KD, Miller GW. Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology. 29: 682-90. PMID 18533268 DOI: 10.1016/J.Neuro.2008.04.010  0.853
2008 Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34. PMID 18533255 DOI: 10.1016/J.Npep.2008.04.003  0.844
2008 Caudle WM, Colebrooke RE, Emson PC, Miller GW. Altered vesicular dopamine storage in Parkinson's disease: a premature demise. Trends in Neurosciences. 31: 303-8. PMID 18471904 DOI: 10.1016/J.Tins.2008.02.010  0.791
2008 Hatcher JM, Pennell KD, Miller GW. Parkinson's disease and pesticides: a toxicological perspective. Trends in Pharmacological Sciences. 29: 322-9. PMID 18453001 DOI: 10.1016/J.Tips.2008.03.007  0.778
2008 Miller GW. Paraquat and parkinson's disease: Response by Dr. Miller, Part II Toxicological Sciences. 103: 222-223. DOI: 10.1093/toxsci/kfn029  0.322
2008 Miller GW. Paraquat and parkinson's disease: Response by Dr. Miller Toxicological Sciences. 103: 217-218. DOI: 10.1093/toxsci/kfm310  0.395
2008 Hatcher JM, Jones DP, Miller GW, Pennell KD. Neurotoxicity of Manufactured Nanoparticles Nanoscience and Nanotechnology: Environmental and Health Impacts. 405-428. DOI: 10.1002/9780470396612.ch16  0.7
2007 Miller GW. Paraquat: the red herring of Parkinson's disease research. Toxicological Sciences : An Official Journal of the Society of Toxicology. 100: 1-2. PMID 17934192 DOI: 10.1093/toxsci/kfm223  0.419
2007 Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 13804-9. PMID 17702867 DOI: 10.1073/Pnas.0702753104  0.475
2007 Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8138-48. PMID 17652604 DOI: 10.1523/Jneurosci.0319-07.2007  0.863
2007 Hamill CE, Caudle WM, Richardson JR, Yuan H, Pennell KD, Greene JG, Miller GW, Traynelis SF. Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1. Molecular Pharmacology. 72: 653-64. PMID 17596374 DOI: 10.1124/Mol.107.038158  0.813
2007 Manning-Bo? AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, Isla MZ, Chou VP, McCormack AL, Miller GW, Langston JW, Gerfen CR, Dimonte DA. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiology of Disease. 27: 141-50. PMID 17560790 DOI: 10.1016/j.nbd.2007.03.014  0.788
2007 Hatcher JM, Richardson JR, Guillot TS, McCormack AL, Di Monte DA, Jones DP, Pennell KD, Miller GW. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Experimental Neurology. 204: 619-30. PMID 17291500 DOI: 10.1016/J.Expneurol.2006.12.020  0.858
2007 Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, Greenamyre JT. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. Journal of Neurochemistry. 100: 1469-79. PMID 17241123 DOI: 10.1111/J.1471-4159.2006.04333.X  0.556
2007 Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB, Sherer TB, Greenamyre JT, Yagi T, Matsuno-Yagi A, Miller GW. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicological Sciences : An Official Journal of the Society of Toxicology. 95: 196-204. PMID 17038483 DOI: 10.1093/Toxsci/Kfl133  0.837
2007 Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 95: 163-71. PMID 17018646 DOI: 10.1093/toxsci/kfl125  0.609
2007 Caudle WM, Tillerson JL, Reverón ME, Miller GW. Use-dependent behavioral and neurochemical asymmetry in MPTP mice. Neuroscience Letters. 418: 213-6. PMID 16603316 DOI: 10.1016/j.neulet.2006.03.045  0.755
2006 Savelieva KV, Caudle WM, Miller GW. Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice. Alcohol (Fayetteville, N.Y.). 40: 87-94. PMID 17307644 DOI: 10.1016/j.alcohol.2006.09.030  0.669
2006 Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1695-7. PMID 16809432 DOI: 10.1096/Fj.06-5864Fje  0.818
2006 Tillerson JL, Caudle WM, Parent JM, Gong C, Schallert T, Miller GW. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behavioural Brain Research. 172: 97-105. PMID 16765459 DOI: 10.1016/j.bbr.2006.04.025  0.74
2006 Caudle WM, Richardson JR, Delea KC, Guillot TS, Wang M, Pennell KD, Miller GW. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. 92: 490-9. PMID 16702228 DOI: 10.1093/Toxsci/Kfl018  0.854
2006 Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicology and Applied Pharmacology. 211: 188-97. PMID 16005927 DOI: 10.1016/j.taap.2005.06.003  0.858
2005 Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicological Sciences : An Official Journal of the Society of Toxicology. 88: 193-201. PMID 16141438 DOI: 10.1093/Toxsci/Kfi304  0.679
2005 Caudle WM, Richardson JR, Wang M, Miller GW. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology. 26: 721-8. PMID 16112329 DOI: 10.1016/j.neuro.2004.09.003  0.817
2005 Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM. Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 343-51. PMID 15647477 DOI: 10.1523/Jneurosci.3252-04.2005  0.311
2004 Rommelfanger KS, Weinshenker D, Miller GW. Reduced MPTP toxicity in noradrenaline transporter knockout mice. Journal of Neurochemistry. 91: 1116-24. PMID 15569255 DOI: 10.1111/J.1471-4159.2004.02785.X  0.558
2004 Richardson JR, Miller GW. Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicology Letters. 148: 29-40. PMID 15019086 DOI: 10.1016/j.toxlet.2003.12.006  0.683
2003 Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10756-64. PMID 14645467 DOI: 10.1523/Jneurosci.23-34-10756.2003  0.563
2003 Tillerson JL, Caudle WM, Reverón ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience. 119: 899-911. PMID 12809709 DOI: 10.1016/S0306-4522(03)00096-4  0.739
2003 Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB. Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience. 117: 417-25. PMID 12614682 DOI: 10.1016/S0306-4522(02)00805-9  0.722
2003 Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. Journal of Neuroscience Methods. 123: 189-200. PMID 12606067 DOI: 10.1016/S0165-0270(02)00360-6  0.512
2002 Tillerson JL, Caudle WM, Reverón ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Experimental Neurology. 178: 80-90. PMID 12460610 DOI: 10.1006/exnr.2002.8021  0.763
2002 Metzger RR, Brown JM, Sandoval V, Rau KS, Elwan MA, Miller GW, Hanson GR, Fleckenstein AE. Inhibitory effect of reserpine on dopamine transporter function. European Journal of Pharmacology. 456: 39-43. PMID 12450567 DOI: 10.1016/S0014-2999(02)02647-X  0.539
2002 Reveron ME, Savelieva KV, Tillerson JL, McCormack AL, Di Monte DA, Miller GW. L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout mice. Neurotoxicology. 23: 611-9. PMID 12428733 DOI: 10.1016/S0161-813X(02)00037-2  0.461
2002 Stephans SE, Miller GW, Levey AI, Greenamyre JT. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology. 23: 569-80. PMID 12428729 DOI: 10.1016/S0161-813X(02)00060-8  0.517
2002 Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW. Forced nonuse in unilateral parkinsonian rats exacerbates injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6790-9. PMID 12151559 DOI: 10.1523/Jneurosci.22-15-06790.2002  0.722
2002 Savelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW. Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcoholism, Clinical and Experimental Research. 26: 758-64. PMID 12068242 DOI: 10.1097/00000374-200206000-00003  0.724
2001 Miller GW, Wang YM, Gainetdinov RR, Caron MG. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine. 62: 179-90. PMID 21318776 DOI: 10.1385/1-59259-142-6:179  0.628
2001 Miller GW, Levey AI. Immunochemical analysis of dopamine transporters in Parkinson's disease. Methods in Molecular Medicine. 62: 167-77. PMID 21318775 DOI: 10.1385/1-59259-142-6:167  0.688
2001 Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4427-35. PMID 11404429 DOI: 10.1523/Jneurosci.21-12-04427.2001  0.421
2001 Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 1982-7. PMID 11172062 DOI: 10.1073/pnas.98.4.1982  0.717
2000 Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience. 3: 465-71. PMID 10769386 DOI: 10.1038/74839  0.792
1999 Miller GW, Kirby ML, Levey AI, Bloomquist JR. Heptachlor alters expression and function of dopamine transporters. Neurotoxicology. 20: 631-7. PMID 10499361  0.627
1999 Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences. 20: 424-9. PMID 10498956 DOI: 10.1016/S0165-6147(99)01379-6  0.744
1999 Sarang SS, Miller GW, Grant DF, Schnellmann RG. Expression and localization of the neuronal glycine receptor beta-subunit in human, rabbit and rat kidneys. Nephron. 82: 254-60. PMID 10395998 DOI: 10.1159/000045410  0.487
1999 Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI. Immunocytochemical localization of the dopamine transporter in human brain. The Journal of Comparative Neurology. 409: 38-56. PMID 10363710 DOI: 10.1002/(Sici)1096-9861(19990621)409:1<38::Aid-Cne4>3.0.Co;2-1  0.616
1999 Miller GW, Erickson JD, Perez JT, Penland SN, Mash DC, Rye DB, Levey AI. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Experimental Neurology. 156: 138-48. PMID 10192785 DOI: 10.1006/Exnr.1998.7008  0.643
1999 Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2424-31. PMID 10087057 DOI: 10.1523/Jneurosci.19-07-02424.1999  0.652
1998 Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381  0.749
1998 Miller GW, Gilmor ML, Levey AI. Generation of transporter-specific antibodies. Methods in Enzymology. 296: 407-22. PMID 9779463 DOI: 10.1016/S0076-6879(98)96029-3  0.476
1998 Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Journal of Neurochemistry. 70: 1973-8. PMID 9572281 DOI: 10.1046/J.1471-4159.1998.70051973.X  0.742
1998 Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. Erratum: Cocaine self-administration in dopamine-transporter knockout mice Nature Neuroscience. 1: 330-330. DOI: 10.1038/1152  0.738
1997 Waters SL, Miller GW, Aleo MD, Schnellmann RG. Neurosteroid inhibition of cell death. American Journal of Physiology. Renal Physiology. 273: F869-F876. PMID 29586117 DOI: 10.1152/ajprenal.1997.273.6.F869  0.448
1997 Waters SL, Miller GW, Aleo MD, Schnellmann RG. Neurosteroid inhibition of cell death. The American Journal of Physiology. 273: F869-76. PMID 9435674 DOI: 10.1152/Ajprenal.1997.273.6.F869  0.514
1997 Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19: 1285-96. PMID 9427251 DOI: 10.1016/S0896-6273(00)80419-5  0.767
1997 Subramanian T, Emerich DF, Bakay RA, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplantation. 6: 469-77. PMID 9331498 DOI: 10.1016/S0963-6897(97)00049-3  0.513
1997 Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Annals of Neurology. 41: 530-9. PMID 9124811 DOI: 10.1002/Ana.410410417  0.617
1997 Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Research. 747: 219-29. PMID 9045996 DOI: 10.1016/S0006-8993(96)01196-1  0.533
1997 Subramanian T, Emerich DF, Bakay RAE, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL. Polymer-Encapsulated PC-12 Cells Demonstrate High-Affinity Uptake of Dopamine in Vitro and18F-DOPA Uptake and Metabolism after Intracerebral Implantation in Nonhuman Primates Cell Transplantation. 6: 469-477. DOI: 10.1177/096368979700600506  0.479
1995 Miller GW, Schnellmann RG. Inhibitors of renal chloride transport do not block toxicant-induced chloride influx in the proximal tubule. Toxicology Letters. 76: 179-84. PMID 7725349 DOI: 10.1016/0378-4274(94)03224-U  0.532
1994 Miller GW, Lock EA, Schnellmann RG. Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicology and Applied Pharmacology. 125: 192-7. PMID 8171427 DOI: 10.1006/taap.1994.1064  0.509
1994 Miller GW, Schnellmann RG. A putative cytoprotective receptor in the kidney: relation to the neuronal strychnine-sensitive glycine receptor. Life Sciences. 55: 27-34. PMID 8015346 DOI: 10.1016/0024-3205(94)90078-7  0.513
1993 Miller GW, Schnellmann RG. Cytoprotection by inhibition of chloride channels: the mechanism of action of glycine and strychnine. Life Sciences. 53: 1211-5. PMID 8412478 DOI: 10.1016/0024-3205(93)90539-F  0.522
1993 Miller GW, Schnellmann RG. A novel low-affinity strychnine binding site on renal proximal tubules: role in toxic cell death. Life Sciences. 53: 1203-9. PMID 8412477 DOI: 10.1016/0024-3205(93)90538-E  0.507
Show low-probability matches.